SWIR Hyperspectral Imaging to Assess Neurocognitive Disorders Using Blood Plasma Samples

Leon, Raquel, Institute of Applied Microelectronics; Hernandez, Abian, Univ. de Las Palmas de Gran Canaria; Fabelo, Himar, Institute of Applied Microelectronics; Ortega, Samuel, Universidad de Las Palmas de Gran Canaria; Balea-Fernandez, Francisco Javier, Univ. de Las Palmas de Gran Canaria; Callicó, Gustavo M., Institute of Applied Microelectronics

doi:10.1117/3.2604326.ch13

Book: Short-Wavelength Infrared Windows for Biomedical Applications

Editor(s): Laura A. Sordillo; Peter P. Sordillo

Author(s): Raquel Leon, Abian Hernandez, Himar Fabelo, Samuel Ortega, Francisco Balea-Fernandez, Gustavo Callicó

Published: 2021

https://doi.org/10.1117/3.2604326.ch13

Author Affiliations +

Abstract

An increase in life expectancy is correlated with an increase in the number of people affected by neurocognitive disorders (NCDs), causing major dependency and disability among the older adult population. Additionally, NCDs are not a natural or unavoidable outcome of aging. These types of disorders are a rapidly growing public health problem with nearly 10 million new cases every year, affecting over 50 million people worldwide in 2019. The most common form of NCD is Alzheimer’s disease (AD), accounting for 60% to 70% of NCD cases.